Next Article in Journal
Identification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Data
Next Article in Special Issue
Genistein Modulates Signaling Pathways and Targets Several Epigenetic Markers in HeLa Cells
Previous Article in Journal
Effects of Fat and Fatty Acids on the Formation of Autolysosomes in the Livers from Yellow Catfish Pelteobagrus Fulvidraco
Previous Article in Special Issue
Investigation of Precise Molecular Mechanistic Action of Tobacco-Associated Carcinogen ‘NNK’ Induced Carcinogenesis: A System Biology Approach

MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential

Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA
Department of Biotechnology, Kumaun University, Nainital, Uttarakhand 263001, India
Department of Internal Medicine, Loyola University Medical Center, Chicago, IL 60153, USA
Biosecurity and Public Health Group, Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA
Department of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
Author to whom correspondence should be addressed.
Received: 31 July 2019 / Revised: 19 September 2019 / Accepted: 20 September 2019 / Published: 25 September 2019
(This article belongs to the Special Issue The Role of Genotoxicity in Infertility and Cancer Development)
Pancreatic cancer is one of the most aggressive malignancies, accounting for more than 45,750 deaths annually in the U.S. alone. The aggressive nature and late diagnosis of pancreatic cancer, coupled with the limitations of existing chemotherapy, present the pressing need for the development of novel therapeutic strategies. Recent reports have demonstrated a critical role of microRNAs (miRNAs) in the initiation, progression, and metastasis of cancer. Furthermore, aberrant expressions of miRNAs have often been associated with the cause and consequence of pancreatic cancer, emphasizing the possible use of miRNAs in the effective management of pancreatic cancer patients. In this review, we provide a brief overview of miRNA biogenesis and its role in fundamental cellular process and miRNA studies in pancreatic cancer patients and animal models. Subsequent sections narrate the role of miRNA in, (i) cell cycle and proliferation; (ii) apoptosis; (iii) invasions and metastasis; and (iv) various cellular signaling pathways. We also describe the role of miRNA’s in pancreatic cancer; (i) diagnosis; (ii) prognosis and (iii) therapeutic intervention. Conclusion section describes the gist of review with future directions. View Full-Text
Keywords: microRNA; pancreatic cancer; diagnosis; prognosis; potential therapeutic targets microRNA; pancreatic cancer; diagnosis; prognosis; potential therapeutic targets
Show Figures

Figure 1

MDPI and ACS Style

Rawat, M.; Kadian, K.; Gupta, Y.; Kumar, A.; Chain, P.S.G.; Kovbasnjuk, O.; Kumar, S.; Parasher, G. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential. Genes 2019, 10, 752.

AMA Style

Rawat M, Kadian K, Gupta Y, Kumar A, Chain PSG, Kovbasnjuk O, Kumar S, Parasher G. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential. Genes. 2019; 10(10):752.

Chicago/Turabian Style

Rawat, Manmeet, Kavita Kadian, Yash Gupta, Anand Kumar, Patrick S.G. Chain, Olga Kovbasnjuk, Suneel Kumar, and Gulshan Parasher. 2019. "MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential" Genes 10, no. 10: 752.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop